Jane Street Group, LLC Eloxx Pharmaceuticals, Inc. Transaction History

Jane Street Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.15 - $7.2 $2,778 - $133,344	18,520 New	18,520 $3,000
Q2 2022 Aug 16, 2022	SELL	$0.24 - $0.58 $4,884 - $11,805	-20,354 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$0.4 - $0.72 $8,141 - $14,654	20,354 New	20,354 $11,000
Q3 2021 Nov 16, 2021	SELL	$1.22 - $2.0 $12,916 - $21,174	-10,587 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$1.35 - $3.36 $14,292 - $35,572	10,587 New	10,587 $21,000

Ticker ELOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,656,200
Description
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis p...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.